Jessica Petrick PhD, MPH

Assistant Professor, Hematology & Medical Oncology

Center Faculty Member, Slone Epidemiology Center

72 E. Concord Street | (617) 206-6179
jpetrick@bu.edu

Sections

Hematology & Medical Oncology

Centers

BU-BMC Cancer Center

Evans Center for Interdisciplinary Biomedical Research

Biography

Dr. Jessica Petrick’s research program focuses on the epidemiology of gastrointestinal cancers, including colorectal, liver, and esophageal. Dr. Petrick became a co-Investigator with the Black Women’s Health Study (BWHS) in 2019, but she has been collaborating with BWHS since she began her post-doctoral fellowship at the National Cancer Institute (NCI) in 2014. BWHS is a member of the NCI Cancer Cohort Consortium and participated in the Liver Cancer Pooling Project, within which Dr. Petrick led numerous studies. The emphasis of her current research portfolio is on nutritional and molecular factors, including the metabolome and microbiome, which may contribute to racial disparities along the cancer continuum—from precursor lesions to invasive cancer through mortality.

Websites

BU Profile

Slone Epidemiology Center Faculty

My NCBI

Google Scholar

ResearchGate

Education

Epidemiology, PhD, University of North Carolina, 2014

Epidemiology/Health Policy, MPH, Case Western Reserve University, 2008

Public Health/Medical Anthropology, BS, Case Western Reserve University, 2007

Publications

Published on 3/25/2023

Petrick JL, Florio AA, Zen J, Wang Y, Gewirtz AT, Pfeiffer RM, Loftus S, Inglefield J, Koshiol J, Yang B, Yu K, Hildesheim A, Chen CJ, Yang HI, Lee MH, McGlynn KA. Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies. Int J Cancer. 2023 Jul 01; 153(1):44-53. PMID: 36878686.

PubMed

Published on 3/21/2023

Long L, Liu X, Petrick J, Liu W, Lee JK, Liao L, Lai MJ, Yang W, Libermann TA, Roberts LR, McGlynn KA, Tabung FK, Zhang X. Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma and chronic liver disease mortality. JNCI Cancer Spectr. 2023 Mar 21. PMID: 36943385.

PubMed

Published on 3/1/2023

Long L, Liu X, Petrick J, Liu W, Lee JK, Liao L, Lai MJ, Yang W, Libermann TA, Roberts LR, McGlynn KA, Tabung FK, Zhang X. Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality. JNCI Cancer Spectr. 2023 Mar 01; 7(2). PMID: 36943385.

PubMed

Published on 12/22/2022

Zhao L, Jin L, Petrick JL, Zeng H, Wang F, Tang L, Smith-Warner SA, Eliassen AH, Zhang FF, Campbell PT, Giovannucci E, Liao LM, McGlynn KA, Steck SE, Zhang X. Specific botanical groups of fruit and vegetable consumption and liver cancer and chronic liver disease mortality: a prospective cohort study. Am J Clin Nutr. 2023 Feb; 117(2):278-285. PMID: 36811575.

PubMed

Published on 11/29/2022

McClain KM, Sampson JN, Petrick JL, Mazzilli KM, Gerszten RE, Clish CB, Purdue MP, Lipworth L, Moore SC. Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Metabolites. 2022 Nov 29; 12(12). PMID: 36557227.

PubMed

Published on 10/27/2022

Argirion I, Brown J, Jackson S, Pfeiffer RM, Lam TK, O'Brien TR, Yu KJ, McGlynn KA, Petrick JL, Pinto LA, Chen CJ, Hildesheim A, Yang HI, Lee MH, Koshiol J. Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort. Cancers (Basel). 2022 Oct 27; 14(21). PMID: 36358697.

PubMed

Published on 9/1/2022

Petrick JL, Barber LE, Rosenberg L. What Are the Factors Underlying Colorectal Cancer Health Disparities? Cancer Prev Res (Phila). 2022 Sep 01; 15(9):561-563. PMID: 36047055.

PubMed

Published on 8/18/2022

Yeoh BS, Saha P, Golonka RM, Zou J, Petrick JL, Abokor AA, Xiao X, Bovilla VR, Bretin ACA, Rivera-Esteban J, Parisi D, Florio AA, Weinstein SJ, Albanes D, Freeman GJ, Gohara AF, Ciudin A, Pericàs JM, Joe B, Schwabe RF, McGlynn KA, Gewirtz AT, Vijay-Kumar M. Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer. Gastroenterology. 2022 Dec; 163(6):1658-1671.e16. PMID: 35988658.

PubMed

Published on 8/12/2022

Yang W, Zeng X, Petrick JL, Danford CJ, Florio AA, Lu B, Nan H, Ma J, Wang L, Zeng H, Sudenga SL, Campbell PT, Giovannucci E, McGlynn KA, Zhang X. Body mass index trajectories, weight gain and risks of liver and biliary tract cancers. JNCI Cancer Spectr. 2022 Aug 12; 6(4). PMID: 35960613.

PubMed

Published on 7/14/2022

Campbell PT, Newton CC, Jacobs EJ, McCullough ML, Wang Y, Rees-Punia E, Guinter MA, Murphy N, Koshiol J, Dehal AN, Rohan T, Strickler H, Petrick J, Gunter M, Zhang X, McGlynn KA, Pollak M, Patel AV, Gapstur SM. Prospective associations of hemoglobin A1c and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort. Cancer Res Commun. 2022 Jul; 2(7):653-662. PMID: 36712480.

PubMed

View full list of 89 publications.